Compounds > platinum
Page last updated: 2024-08-22

platinum and Hearing Loss

platinum has been researched along with Hearing Loss in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (6.25)18.2507
2000's1 (6.25)29.6817
2010's7 (43.75)24.3611
2020's7 (43.75)2.80

Authors

AuthorsStudies
Cardonick, EH; Finch, LE1
Brigato, F; De Corso, E; Fetoni, AR; Galli, J; Lucidi, D; Ruggiero, A; Scarano, E; Sergi, B1
Am Zehnhoff-Dinnesen, A; Ansari, M; Kompis, M; Kuehni, CE; Mader, L; Parfitt, R; Sláma, T; Strebel, S; von der Weid, NX; Waespe, N; Weiss, A1
Chadha, S; Dillard, LK; Fullerton, AM; Lopez-Perez, L; Martinez, RX; McMahon, CM1
Abrams, G; Alfaro, E; Cheung, S; Conley, Y; Cooper, B; Henderson-Sabes, J; Levine, J; Mastick, J; Miaskowski, C; Paul, S; Quinn, M; Snowberg, K; Wallhagen, M1
Ahmed, R; Attia, M; Hanna, D; Kamal, NM; Oshi, MAM; Rifky, E; Sherief, LM1
Akeroyd, MA; Baguley, DM; Pearson, SE; Phillips, OR1
Chuang, A; Cordova, M; Del Valle, Á; Waissbluth, S1
Bremnes, RM; Brydøy, M; Fosså, SD; Gundersen, POM; Haugnes, HS; Hellesnes, R; Hjelle, LV; Oldenburg, J; Sprauten, M; Tandstad, T; Wilsgaard, T1
Brooks, B; Carleton, B; Clemens, E; de Vries, ACH; van den Heuvel-Eibrink, MM; van Grotel, M1
Chai, R; Guo, J; Li, H; Sun, S1
Castanheira, I; Ciarimboli, G; Karst, U; Köppen, C; Reifschneider, O; Sperling, M1
Bunne, M; Fosså, SD; Gundersen, POM; Osnes, T; Skalleberg, J; Småstuen, MC; Solheim, O1
Klis, SF; Sepmeijer, JW1
Allman, BL; Ding, D; Salvi, R1
Lautermann, J; McLaren, J; Schacht, J; Song, B1

Reviews

4 review(s) available for platinum and Hearing Loss

ArticleYear
Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: A systematic review and meta-analysis.
    Cancer epidemiology, 2022, Volume: 79

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Hearing Loss; Humans; Neoplasms; Ototoxicity; Platinum

2022
The long-term impacts of hearing loss, tinnitus and poor balance on the quality of life of people living with and beyond cancer after platinum-based chemotherapy: a literature review.
    Journal of cancer survivorship : research and practice, 2023, Volume: 17, Issue:1

    Topics: Adult; Antineoplastic Agents; Cancer Survivors; Carboplatin; Child; Cisplatin; Hearing Loss; Humans; Neoplasms; Ototoxicity; Platinum; Quality of Life; Tinnitus

2023
Protection of Hair Cells from Ototoxic Drug-Induced Hearing Loss.
    Advances in experimental medicine and biology, 2019, Volume: 1130

    Topics: Aminoglycosides; Antineoplastic Agents; Diuretics; Hair Cells, Auditory; Hearing Loss; Humans; Platinum

2019
Review: ototoxic characteristics of platinum antitumor drugs.
    Anatomical record (Hoboken, N.J. : 2007), 2012, Volume: 295, Issue:11

    Topics: Animals; Antineoplastic Agents; Cochlea; Hair Cells, Auditory; Hearing Loss; Humans; Platinum

2012

Other Studies

12 other study(ies) available for platinum and Hearing Loss

ArticleYear
Incidence of childhood hearing loss after in utero exposure to platinum agents.
    Prenatal diagnosis, 2021, Volume: 41, Issue:11

    Topics: Antineoplastic Agents; Child; Cohort Studies; Drug Therapy; Environmental Exposure; Female; Hearing Loss; Humans; Incidence; Infant; Infant, Newborn; Platinum; Pregnancy

2021
Long-term auditory follow-up in the management of pediatric platinum-induced ototoxicity.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2022, Volume: 279, Issue:10

    Topics: Antineoplastic Agents; Carboplatin; Child; Cisplatin; Follow-Up Studies; Hearing Loss; Humans; Ototoxicity; Platinum; Platinum Compounds

2022
Severity of hearing loss after platinum chemotherapy in childhood cancer survivors.
    Pediatric blood & cancer, 2022, Volume: 69, Issue:9

    Topics: Antineoplastic Agents; Cancer Survivors; Carboplatin; Child; Cisplatin; Hearing Loss; Humans; Neoplasms; Platinum

2022
Cancer survivors and neurotoxic chemotherapy: hearing loss and tinnitus.
    BMJ supportive & palliative care, 2023, Volume: 13, Issue:3

    Topics: Cancer Survivors; Hearing Loss; Humans; Neoplasms; Nutrition Surveys; Platinum; Taxoids; Tinnitus; United States

2023
Platinum-induced ototoxicity in pediatric cancer survivors: GSTP1 c.313A>G variant association.
    Medicine, 2022, Nov-11, Volume: 101, Issue:45

    Topics: Cancer Survivors; Carboplatin; Child; Cisplatin; Cross-Sectional Studies; Deafness; Glutathione S-Transferase pi; Hearing Loss; Humans; Neoplasms; Ototoxicity; Platinum

2022
Long term platinum-induced ototoxicity in pediatric patients.
    International journal of pediatric otorhinolaryngology, 2018, Volume: 107

    Topics: Adolescent; Antineoplastic Agents; Audiometry; Child; Child, Preschool; Cohort Studies; Disease Progression; Female; Hearing Loss; Humans; Incidence; Infant; Male; Neoplasms; Platinum; Prospective Studies; Surveys and Questionnaires

2018
Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors.
    Acta oncologica (Stockholm, Sweden), 2018, Volume: 57, Issue:10

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cancer Survivors; Cisplatin; Hearing Loss; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Platinum; Testicular Neoplasms; Young Adult

2018
A comparison of the Muenster, SIOP Boston, Brock, Chang and CTCAEv4.03 ototoxicity grading scales applied to 3,799 audiograms of childhood cancer patients treated with platinum-based chemotherapy.
    PloS one, 2019, Volume: 14, Issue:2

    Topics: Antineoplastic Agents; Audiometry; Carboplatin; Child; Cisplatin; Female; Hearing Loss; Humans; Male; Neoplasms; Platinum

2019
Quantitative imaging of platinum based on laser ablation-inductively coupled plasma-mass spectrometry to investigate toxic side effects of cisplatin.
    Metallomics : integrated biometal science, 2015, Volume: 7, Issue:12

    Topics: Animals; Cisplatin; Cochlea; Hearing Loss; Infertility, Male; Male; Mass Spectrometry; Mice; Molecular Imaging; Platinum; Testis

2015
Long-term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer.
    Gynecologic oncology, 2017, Volume: 145, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Audiometry, Pure-Tone; Bleomycin; Case-Control Studies; Chemotherapy, Adjuvant; Child; Cisplatin; Etoposide; Female; Hearing Loss; Humans; Longitudinal Studies; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Ovariectomy; Platinum; Vinblastine; Young Adult

2017
Distribution of platinum in blood and perilymph in relation to cisplatin induced ototoxicity in the guinea pig.
    Hearing research, 2009, Volume: 247, Issue:1

    Topics: Action Potentials; Animals; Antineoplastic Agents; Auditory Threshold; Cisplatin; Cochlea; Dose-Response Relationship, Drug; Electrodes; Guinea Pigs; Hearing Loss; Male; Models, Animal; Perilymph; Platinum

2009
Diet is a risk factor in cisplatin ototoxicity.
    Hearing research, 1995, Volume: 88, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Blood Urea Nitrogen; Cisplatin; Cochlea; Creatinine; Dietary Proteins; Glutathione; Guinea Pigs; Hearing Loss; Injections, Subcutaneous; Male; Platinum; Serum Albumin; Weight Gain

1995